Systemic therapy in the management of metastatic or advanced salivary gland cancers

Salivary gland cancers are very rare tumors. They are characterized by a histologic heterogeneity and a poor outcome.

According to this rarity, few prospective data are available to date. No standard recommendations could be held for the use of systemic therapy in these tumors.

Several case reports and small studies have investigated the contribution of different agents of chemotherapy. With the extension of molecular biology approach in oncology several signaling pathways have been discovered in different cancers including salivary gland cancers; thus a number of targeted therapies have been investigated.

This paper reviewed exhaustively the studies investigating the role of systemic therapies (chemotherapy, targeted therapy, hormone therapy) in salivary gland cancers.

Author: Aymen LaghaNesrine ChraietMouna AyadiSarra KrimiBassem AllaniHela RifiHenda RaiesAmel Mezlini
Credits/Source: Head &Neck Oncology 2012, 4:19

Published on: 2012-05-04

Copyright by the authors listed above - made available via BioMedCentral (Open Access). Please make sure to read our disclaimer prior to contacting 7thSpace Interactive. To contact our editors, visit our online helpdesk. If you wish submit your own press release, click here.

Comments

There are no comments available. Be the first to write a comment.

You need to enable Javascript to post a comment.

Custom Search